デフォルト表紙
市場調査レポート
商品コード
1593863

肝臓用サプリメント市場:製品・剤形別-2025-2030年世界予測

Liver Health Supplements Market by Product (Herbal Supplements, Vitamins & Minerals), Dosage Form (Capsules, Liquids, Powders) - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 185 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
肝臓用サプリメント市場:製品・剤形別-2025-2030年世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 185 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

肝臓用サプリメント市場は、2023年に11億7,000万米ドルと評価され、2024年には12億9,000万米ドルに達すると予測され、CAGR 10.46%で成長し、2030年には23億6,000万米ドルに達すると予測されています。

世界の肝臓用サプリメント市場には、肝機能と解毒プロセスをサポートするために処方された製品が含まれます。主に栄養補助食品やハーブサプリメントとして定義されるこれらの製品は、肝臓の健康維持や改善を求める個人を対象としています。肝臓用サプリメントの必要性は、不健康な食生活、アルコール消費、肝臓関連疾患の有病率の上昇、肝臓の健康に対する意識の高まりといった要因から生じています。用途は、予防的な健康、解毒、肝臓の懸念に関連する症状の緩和に焦点を当てた様々な層に広がっています。最終用途の範囲には、主に個人消費者が含まれるが、予防対策を提唱するヘルスケアやウェルネスセンターにも広がっています。

主な市場の統計
基準年[2023] 11億7,000万米ドル
予測年[2024] 12億9,000万米ドル
予測年[2030] 23億6,000万米ドル
CAGR(%) 10.46%

市場成長の主な要因としては、肝臓の健康に対する消費者の意識の高まり、予防医療の台頭、健康サプリメントへの支出を可能にする可処分所得の増加などが挙げられます。ヘルスケアに対する意識が向上し、経済が発展している新興国市場にも大きなビジネスチャンスがあります。オンライン販売チャネルの急増により、製品へのアクセスや流通が促進され、市場へのリーチが拡大しています。こうした機会を活用するため、企業は肝臓の健康維持のメリットについて消費者を啓蒙することに重点を置いた、的を絞ったマーケティング戦略に投資すべきです。

しかし、市場の成長は、規制上の課題、製品の信頼性に関する懸念、サプリメントの有効性に関する消費者のさまざまな認識といった制約に直面しています。さらに、厳しい品質管理要件や医薬品との競合が市場拡大の妨げとなる可能性もあります。特にハーブ製剤では、原材料の品質が不確かであることがさらなる課題となっています。

技術革新は、臨床的に証明された製剤の開発、遺伝的要因や生活習慣に基づく個別化栄養補助食品の開発、製品の信頼性を確保するための第三者機関による試験の共同実施に重点を置くべきです。副作用なしに肝臓に特異的な効果をもたらす天然化合物の調査は、事業成長の有望分野です。消費者の嗜好は進化しており、天然成分やオーガニック成分へのシフトが顕著です。AI主導のサプリメントなど、個別化された健康ソリューションのためのテクノロジーを取り入れることは、この競合情勢において差別化をさらに生み出すことができます。

市場力学:急速に進化する肝臓用サプリメント市場の主要市場インサイトを公開

肝臓用サプリメント市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響についてより明確に理解することができます。

  • 市場促進要因
    • 肝がんや脂肪肝などの肝疾患の世界の罹患率の増加
    • アルコール消費の増加に伴う需要の増加
    • 若年層および成人における肥満の急増
  • 市場抑制要因
    • 肝臓用サプリメントの高コスト
  • 市場機会
    • eコマースなど消費者の購買パターンの変化に伴う意識の高まり
    • 新しいサプリメントの導入による新たな展開
  • 市場の課題
    • 血液凝固能の低下、黄疸、腹部腫脹などの健康関連リスク

ポーターの5つの力:肝臓用サプリメント市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:肝臓用サプリメント市場における外部からの影響の把握

外部マクロ環境要因は、肝臓用サプリメント市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析肝臓用サプリメント市場における競合情勢の把握

肝臓用サプリメント市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス肝臓用サプリメント市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、肝臓用サプリメント市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨肝臓用サプリメント市場における成功への道筋を描く

肝臓用サプリメント市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 肝臓がんや脂肪肝などの肝臓疾患の発生が世界的に増加している
      • アルコール消費量の増加に伴う需要の高まり
      • 若者と成人の肥満が急増
    • 抑制要因
      • 肝臓用サプリメントのコストが高い
    • 機会
      • eコマースなど消費者の購買パターンの変化による意識の高まり
      • 新しいサプリメントのイントロダクションよる新たな展開
    • 課題
      • 血液凝固の低下、黄疸、腹部の腫れなどの健康関連リスク
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 肝臓用サプリメント市場:製品別

  • ハーブサプリメント
  • ビタミンとミネラル

第7章 肝臓用サプリメント市場剤形別

  • カプセル
  • 液体
  • 粉末
  • タブレット

第8章 南北アメリカの肝臓用サプリメント市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の肝臓用サプリメント市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの肝臓用サプリメント市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • AIE Pharmaceuticals, Inc
  • aland Health Holding Ltd.
  • Amway Corporation
  • BASF SE
  • Bio-Botanica
  • DSM Nutritional Products AG
  • Enzymedica
  • Gaia Herbs
  • Herbal Supplements Pvt Ltd
  • Hetero Healthcare Limited
  • Integria Healthcare(Australia)Pty Ltd
  • Irwin Naturals
  • Nature's Craft-Luxurious Naturveda
  • NOW Health Group, Inc
  • Nutralife Health Products Inc
  • ParkAcre Ltd
  • Sunfood Nutraceuticals, Inc
  • Swisse Wellness PTY LTD
  • The Himalaya Drug Company
  • The Nature's Bounty Co.
図表

LIST OF FIGURES

  • FIGURE 1. LIVER HEALTH SUPPLEMENTS MARKET RESEARCH PROCESS
  • FIGURE 2. LIVER HEALTH SUPPLEMENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL LIVER HEALTH SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. LIVER HEALTH SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. LIVER HEALTH SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. LIVER HEALTH SUPPLEMENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL LIVER HEALTH SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. LIVER HEALTH SUPPLEMENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY HERBAL SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM LIVER HEALTH SUPPLEMENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 101. LIVER HEALTH SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. LIVER HEALTH SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-B9334AD6C0D9

The Liver Health Supplements Market was valued at USD 1.17 billion in 2023, expected to reach USD 1.29 billion in 2024, and is projected to grow at a CAGR of 10.46%, to USD 2.36 billion by 2030.

The global liver health supplements market involves products formulated to support liver function and detoxification processes. Defined primarily as dietary or herbal supplements, these products cater to individuals seeking to maintain or improve liver health. The necessity of liver health supplements arises from factors such as unhealthy diets, alcohol consumption, rising prevalence of liver-related disorders, and increased awareness about liver health. Applications extend across various demographics focusing on preventive health, detoxification, and alleviating symptoms associated with liver concerns. The end-use scope primarily includes individual consumers, but also spans into healthcare and wellness centers advocating preventive measures.

KEY MARKET STATISTICS
Base Year [2023] USD 1.17 billion
Estimated Year [2024] USD 1.29 billion
Forecast Year [2030] USD 2.36 billion
CAGR (%) 10.46%

Key market growth influencers include increasing consumer awareness about liver health, the rise of preventive healthcare, and growing disposable incomes allowing for expenditure on health supplements. Emerging markets with improving healthcare awareness and economic development also present substantial opportunities. An upsurge in online sales channels enhances product accessibility and distribution, expanding market reach. To harness these opportunities, companies should invest in targeted marketing strategies that focus on educating consumers about the benefits of maintaining liver health.

However, market growth faces limitations from regulatory challenges, product reliability concerns, and varying consumer perceptions about supplement efficacy. Moreover, stringent quality control requirements and competition from pharmaceuticals can hinder expansion. Uncertainties in raw material quality, particularly in herbal formulations, present additional challenges.

Innovation should focus on the development of clinically proven formulations, personalized nutritional supplements based on genetic and lifestyle factors, and collaborations for third-party testing to ensure product credibility. Research into natural compounds that provide liver-specific benefits without adverse effects is a promising area for business growth. The market is characterized by evolving consumer preferences, with a pronounced shift towards natural and organic ingredients, which demand businesses to adapt swiftly and innovatively. Embracing technology for personalized health solutions, such as AI-driven supplements, can further create differentiation in this competitive landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Liver Health Supplements Market

The Liver Health Supplements Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidence of liver diseases such as liver cancer and fatty liver disease globally
    • Rising demand pertinent to increasing consumption of alcohol
    • Surge in obesity among young and adult population
  • Market Restraints
    • High cost of liver health supplements
  • Market Opportunities
    • Increasing awareness with changing buying patterns of consumers such as e-commerce
    • Emerging developments with the introduction of new supplements
  • Market Challenges
    • Health associated risks such as reduced blood clotting, jaundice and abdominal swelling

Porter's Five Forces: A Strategic Tool for Navigating the Liver Health Supplements Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Liver Health Supplements Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Liver Health Supplements Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Liver Health Supplements Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Liver Health Supplements Market

A detailed market share analysis in the Liver Health Supplements Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Liver Health Supplements Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Liver Health Supplements Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Liver Health Supplements Market

A strategic analysis of the Liver Health Supplements Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Liver Health Supplements Market, highlighting leading vendors and their innovative profiles. These include AIE Pharmaceuticals, Inc, aland Health Holding Ltd., Amway Corporation, BASF SE, Bio-Botanica, DSM Nutritional Products AG, Enzymedica, Gaia Herbs, Herbal Supplements Pvt Ltd, Hetero Healthcare Limited, Integria Healthcare (Australia) Pty Ltd, Irwin Naturals, Nature's Craft - Luxurious Naturveda, NOW Health Group, Inc, Nutralife Health Products Inc, ParkAcre Ltd, Sunfood Nutraceuticals, Inc, Swisse Wellness PTY LTD, The Himalaya Drug Company, and The Nature's Bounty Co..

Market Segmentation & Coverage

This research report categorizes the Liver Health Supplements Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Herbal Supplements and Vitamins & Minerals.
  • Based on Dosage Form, market is studied across Capsules, Liquids, Powders, and Tablets.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of liver diseases such as liver cancer and fatty liver disease globally
      • 5.1.1.2. Rising demand pertinent to increasing consumption of alcohol
      • 5.1.1.3. Surge in obesity among young and adult population
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of liver health supplements
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing awareness with changing buying patterns of consumers such as e-commerce
      • 5.1.3.2. Emerging developments with the introduction of new supplements
    • 5.1.4. Challenges
      • 5.1.4.1. Health associated risks such as reduced blood clotting, jaundice and abdominal swelling
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Liver Health Supplements Market, by Product

  • 6.1. Introduction
  • 6.2. Herbal Supplements
  • 6.3. Vitamins & Minerals

7. Liver Health Supplements Market, by Dosage Form

  • 7.1. Introduction
  • 7.2. Capsules
  • 7.3. Liquids
  • 7.4. Powders
  • 7.5. Tablets

8. Americas Liver Health Supplements Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Liver Health Supplements Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Liver Health Supplements Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AIE Pharmaceuticals, Inc
  • 2. aland Health Holding Ltd.
  • 3. Amway Corporation
  • 4. BASF SE
  • 5. Bio-Botanica
  • 6. DSM Nutritional Products AG
  • 7. Enzymedica
  • 8. Gaia Herbs
  • 9. Herbal Supplements Pvt Ltd
  • 10. Hetero Healthcare Limited
  • 11. Integria Healthcare (Australia) Pty Ltd
  • 12. Irwin Naturals
  • 13. Nature's Craft - Luxurious Naturveda
  • 14. NOW Health Group, Inc
  • 15. Nutralife Health Products Inc
  • 16. ParkAcre Ltd
  • 17. Sunfood Nutraceuticals, Inc
  • 18. Swisse Wellness PTY LTD
  • 19. The Himalaya Drug Company
  • 20. The Nature's Bounty Co.